Acute transudative otitis media

Summary

Acute transudative otitis media (MONDO:0002738) is a disease. A subtype of non-suppurative otitis media — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	acute transudative otitis media
Mondo ID	MONDO:0002738
DOID	DOID:3697
SNOMED CT	359609001
UMLS	C0271432
MedGen	543339
Is cancer (heuristic)	no

Also known as: acute nonsuppurative otitis media · non-suppurative otitis media, acute

Disease family

This is a subtype of non-suppurative otitis media. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by body system or component › auditory system disorder › middle ear disorder › otitis media › non-suppurative otitis media › acute transudative otitis media

Related subtypes (2): serous otitis media, chronic non-suppurative otitis media

Subtypes (3): acute serous otitis media, acute sanguinous otitis media, blue drum syndrome

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.